175 related articles for article (PubMed ID: 2239570)
61. [Clinical study on aztreonam in pediatrics].
Niino M; Kida K; Matsuda H; Murase M
Jpn J Antibiot; 1985 Nov; 38(11):3334-42. PubMed ID: 4094066
[TBL] [Abstract][Full Text] [Related]
62. [Indications and limits in the use of fosfomycin in urology. Preliminary notes].
Meazza A; Marzorati G
Minerva Med; 1978 Dec; 69(59):4107-9. PubMed ID: 740307
[No Abstract] [Full Text] [Related]
63. ZTI-01 (fosfomycin for injection) in the treatment of hospitalized patients with complicated urinary tract infections.
Burgos RM; Rodvold KA
Future Microbiol; 2019 Apr; 14():461-475. PubMed ID: 30854892
[TBL] [Abstract][Full Text] [Related]
64. [Clinical evaluation of a combination therapy with aztreonam and clindamycin for severe infections in leukemia and related disorders].
Tsuda S; Tanaka S; Nakagawa H; Nishigaki H; Okuda T; Horiike S; Taniwaki M; Misawa S; Inazawa J; Abe T
Jpn J Antibiot; 1989 Sep; 42(9):1926-37. PubMed ID: 2810755
[TBL] [Abstract][Full Text] [Related]
65. Clinical studies of aztreonam in Japan.
Hara K; Kobayashi H; Nishiura T; Yura J; Saito A
Rev Infect Dis; 1985; 7 Suppl 4():S810-24. PubMed ID: 3909341
[TBL] [Abstract][Full Text] [Related]
66. [Urinary tract infection caused by Actinobaculum schaalii in an elderly patient].
García-Bravo M; González-Fernández MB; García-Castro MA; Jaime-Muniesa ML
Rev Esp Quimioter; 2011 Mar; 24(1):52-3. PubMed ID: 21412672
[No Abstract] [Full Text] [Related]
67. [Clinical experience with cefbuperazone in complicated urinary tract infection].
Banya Y; Okamoto T; Ujiie T; Yoo T; Noro K; Niisato S; Yokota K; Aoki H; Kubo T; Ohhori T
Hinyokika Kiyo; 1987 May; 33(5):786-93. PubMed ID: 3661345
[TBL] [Abstract][Full Text] [Related]
68. Usefulness and problems of the urinary tract infection criteria for evaluating drug efficacy for complicated urinary tract infections.
Arakawa S; Tanaka K; Miura T; Shigemura K; Takenaka A; Matsui T; Kamidono S; Nakano Y; Fujisawa M
J Infect Chemother; 2007 Oct; 13(5):279-84. PubMed ID: 17982714
[TBL] [Abstract][Full Text] [Related]
69. [Treatment of urinary tract infections with a new antibiotic: phosphomycin (author's transl)].
Ruiloba J; Fortuño VE; Ruiz G; Gallo S
Rev Invest Clin; 1976; 28(1):29-32. PubMed ID: 775587
[No Abstract] [Full Text] [Related]
70. [Investigation on effectiveness and safety of fosfomycin in treatment of patients with allergy induced by antibacterial agents].
Suzuki K; Tamai H
Jpn J Antibiot; 1986 Jan; 39(1):141-53. PubMed ID: 3702056
[TBL] [Abstract][Full Text] [Related]
71. Fosfomycin in the treatment of bacterial infections: summary of clinical trials in Japan.
Fujii R
Chemotherapy; 1977; 23 Suppl 1():234-46. PubMed ID: 832522
[TBL] [Abstract][Full Text] [Related]
72. An open study of the efficacy and safety of single dose fosfomycin trometamol in treatment of hospitalised patients with urinary tract infection (pilot study).
MacGowan AP; Bailey RA; Egner W; Picken DM; Reeves DS
Infection; 1990; 18 Suppl 2():S107-8. PubMed ID: 2286455
[TBL] [Abstract][Full Text] [Related]
73. Clinical experience with aztreonam in four Mediterranean countries.
Daikos GK
Rev Infect Dis; 1985; 7 Suppl 4():S831-5. PubMed ID: 2934787
[TBL] [Abstract][Full Text] [Related]
74. [Clinical effects of a combination treatment with fosfomycin and clavulanic acid/ticarcillin for infections in patients complicated with hematological disorders].
Hirakawa K; Tsuda S; Misawa S; Ueda Y; Kaneko H; Nakao M; Ariyama Y; Nakai H; Seriu T; Takashima T
Jpn J Antibiot; 1994 May; 47(5):521-9. PubMed ID: 8051794
[TBL] [Abstract][Full Text] [Related]
75. The clinical use of aztreonam.
Schönwald S; Schoss-Vidensek Z; Car V; Krznar B
Chemotherapy; 1989; 35 Suppl 1():45-8. PubMed ID: 2731450
[TBL] [Abstract][Full Text] [Related]
76. [Clinical evaluation of fosfomycin].
Lan CK
Zhonghua Yi Xue Za Zhi (Taipei); 1990 Mar; 45(3):181-5. PubMed ID: 2168262
[TBL] [Abstract][Full Text] [Related]
77. Pharmacokinetics, in-vitro activity, therapeutic efficacy and clinical safety of aztreonam vs. cefotaxime in the treatment of complicated urinary tract infections.
Naber KG; Dette GA; Kees F; Knothe H; Grobecker H
J Antimicrob Chemother; 1986 Apr; 17(4):517-27. PubMed ID: 3710959
[TBL] [Abstract][Full Text] [Related]
78. Fosfomycin in treatment of chronic urinary tract infection.
Gobernado M; Oleza J; Santos M; Roman J; Paz M; Mascaros E; Almela J
Chemotherapy; 1975; 21(2):99-107. PubMed ID: 1157571
[TBL] [Abstract][Full Text] [Related]
79. Daily fosfomycin versus levofloxacin for complicated urinary tract infections.
Rouphael N; Winokur P; Keefer MC; Traenkner J; Drobeniuc A; Doi Y; Munsiff S; Fowler VG; Evans S; Oler RE; Tuyishimire B; Lee M; Ghazaryan V; Chambers HF;
mBio; 2023 Oct; 14(5):e0167723. PubMed ID: 37698412
[TBL] [Abstract][Full Text] [Related]
80. [Clinical evaluation of a combination treatment with cefminox and fosfomycin for infections complicated in patients with hematological disorders].
Seriu T; Tsuda S; Nakai H; Murakami T; Takashima T; Takahashi Y; Tanaka S; Nakagawa H; Nishigaki H; Yokota S
Jpn J Antibiot; 1991 Nov; 44(11):1197-205. PubMed ID: 1784070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
